Koji Muroya

Also affiliated with Foundation for Growth Science

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period”.

Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period

JBMR Plus(2024)10.1093/jbmrpl/ziad001

N/A

0DataRank · unranked

20 citations

Wolfgang Högler, Francis H. Glorieux, Anthony A. Portale, Michael P. Whyte, Craig F. Munns +16 more